Bioanalytical method development and validation for quantification of amivantamab in rat plasma by LC-MS/MS
Abstract Background Amivantamab is a monoclonal bispecific anti-EGFR-MET antibody used to treat non-small cell lung cancer. There were no published methods using a liquid chromatographic-tandem mass spectrometric approach to develop and validate a feasible, novel, and thoroughly validated method for...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
SpringerOpen,
2024-04-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|